Cureatr Inc. acquired SinfoníaRx business of Tabula Rasa HealthCare, Inc on March 2, 2023. Tabula Rasa HealthCare, Inc completed the sale of its SinfoníaRx business to Cureatr, following the sale of its DoseMeRx business to an affiliate of Fairlong Capital LLC earlier this year. The combined proceeds are $11 million.

Cureatr Inc. completed the acquisition of SinfoníaRx business of Tabula Rasa HealthCare, Inc on March 2, 2023.